Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?
The article “Where are we with the use of N-acetylcysteine as a preventive and adjuvant treatment for COVID-19?”, published in the European Review for Medical and Pharmacological Sciences by Di Marco et al., examines the potential role of N-acetylcysteine (NAC) as a preventive and supportive treatment for severe COVID-19.
The clinical and experimental evidence reviewed in the study suggests that N-acetylcysteine may act on mechanisms involved in the prothrombotic state observed in patients with severe COVID-19 infection, potentially helping reduce complications and disease severity.